FisherMM.Tryptase in anaphylaxis. Anaesth Intens Care1991; 19(3):479.
2.
SchwartzLB, MetcalfeD, MillerJ, EarleH, SullivanT.Tryptase levels as an indicator of mast cell activation in systemic anaphylaxis and mastocytosis. N Engl J Med1987; 316:1622–1626.
3.
WatkinsJ.Adverse reaction to neuromuscular blockers: frequency, investigation, and epidemiology. Acta Anaesthesiol Scand1994; 38(Suppl 102):6–10.
4.
FisherM.Intradermal testing after anaphylactoid reaction to anaesthetic drugs: Practical aspects of performance and interpretation. Anaesth Intens Care1984; 12:115–120.
5.
FisherMM, BaldoBA.The incidence and clinical features of anaphylactic reactions during anaesthesia in Australia. Ann Fr Anesth Reanim1993; 12(2):97–104.
6.
PepysJ, PepysEO, BaldoBA, WhitwamJG.Anaphylactic/ana-phylactoid reactions to anaesthetic and associated agents. Skin prick tests in aetiological diagnosis. Anaesthesia1994; 49(6):470–475.
7.
LaxenaireMC.Drugs and other agents involved in anaphylactic shock occurring during anaesthesia. A French multicenter epidemiological inquiry. Ann Fr Anesth Reanim1993; 12(2): 91–96.
8.
SavareseJJ, HassanHA, BastaSJ, et al. The cardiovascular effects of mivacurium chloride in patients receiving nitrous oxide-opiate-barbiturate anaesthesia. Anaesthesiology1989; 70:386–394.
9.
UK Prescribing Information, Mivacurium, The Wellcome Foundation, 1993.
10.
BastaSJ, SavareseJJ, AliHH, MossJ, GionfriddoM.Histamine releasing potencies of atracurium, dimethyl tubocurarine and tubocurarine. Br J Anaesth1983; 55:105–106S.
11.
ScottRPF, SavareseJJ, et al. Atracurium: Clinical strategies for preventing histamine release and attenuating the haemo-dynamic response. Br J Anaesth1985; 57:550–553.
